Navigation

Neuropathic pain - pharmacological management

Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings

Status: History
Publication date: November 2013
Wave: 0
Process: SCG
Topic area:
 

NICE project team

Centre for clinical practice lead: Sarah Willett
Communications manager: Lyndsey Unwin
Guidelines commissioning manager:

Clifford Middleton

Guidelines coordinator: Rebecca Pye
Patient involvement lead: Erin Whittingham
Implementation lead: Heather Stephens
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Consultation on draft scope with stakeholders: 11 June - 9 July 2012
Consultation on draft guideline with stakeholders: 19 June - 17 July 2013
Publication date: November 2013
Top


 

Project history

Date Update
20 November 2013 Guideline published - CG173 Neuropathic pain - pharmacological management
18 July 2013 Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received.
18 June 2013 The draft guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

03 August 2012

 

The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.
June 2012 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
23 March 2012 NICE will fully update its clinical guideline on the pharmacological management of neuropathic pain in non-specialist settings in order to address ongoing uncertainties regarding the cost effectiveness of some of the recommended treatment options.  The planned update is not related to the safety or clinical efficacy of the drugs. Until a further announcement is made, the original guideline (CG96) continues to represent best practice for the NHS.
Top


 

Key documents

This page was last updated: 22 November 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.